{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:11:05Z","timestamp":1764173465280},"reference-count":43,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Aetiopathogenesis of psoriasis is complex and not yet well known. In recent years, it has been observed that psoriasis can coexist with clinically asymptomatic celiac disease and a gluten\u2010free diet helps to obtain remission, even in patients with very chronic lesions.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> The aim of our work was to investigate how often the positive titres of antibodies characteristic for celiac disease occur in psoriatics\u2019 serum in exacerbation in comparison with controls.<\/jats:p><jats:p><jats:bold>Patients\/methods\u2002<\/jats:bold> Serum samples from 67 patients with intensified psoriatic lesions were investigated. Serum from healthy people at a comparable age and with no familial predisposition to psoriasis and celiac disease was the control material. Antibodies against human tissue transglutaminase (recombinant antigen), against tissue transglutaminase isolated from guinea pig's liver and against gliadin were determined by enzyme\u2010linked immunosorbent assay technique. Anti\u2010endomysial antibodies were determined by indirect immunofluorescence method.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Patients with psoriasis have significantly higher mean concentrations of antibodies against tissue transglutaminase (human recombinant and guinea pig\u2010derived antigen) and against gliadin for IgA. IgA antibodies against tissue transglutaminase (both antigens) and gliadin positively correlate with psoriasis activity. No anti\u2010endomysial antibodies for IgA were found in any serum.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Our results seem to imply an association between psoriasis and asymptomatic celiac disease\/gluten intolerance. High percentage of positive results to guinea pig\u2010derived tTG could be due to cellular activity of tissue transglutaminase in psoriasis.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2008.02713.x","type":"journal-article","created":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T22:06:33Z","timestamp":1207087593000},"page":"1055-1061","source":"Crossref","is-referenced-by-count":24,"title":["Serologic markers of celiac disease in psoriatic patients"],"prefix":"10.1111","volume":"22","author":[{"given":"A","family":"Damasiewicz\u2010Bodzek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Wielkoszy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0923-1811(91)90057-5"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246487"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03240.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2340\/000155557190","article-title":"How common is gluten intolerance among patients with psoriasis?","volume":"71","author":"Micha\u00eblsson G","year":"1991","journal-title":"Acta Derm Venerol (Stockh)"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000073220"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520212496"},{"key":"e_1_2_5_8_2","first-page":"361","article-title":"Serum antibodies in celiac disease","volume":"46","author":"Dieterich W","year":"2000","journal-title":"Clin Lab"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.66.8.941"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61732-1"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.104.1.75"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1080\/028134300750018990"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0797-797"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70008-3"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/45.12.2142"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02018.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200004000-00006"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655201750313388"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-14883"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1568-9972(03)00065-X"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)01717-9"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1982.tb02465.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb03329.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.1.31"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2340\/0001555560348351","article-title":"Antireticulin antibodies in psoriasis","volume":"60","author":"Siri A","year":"1980","journal-title":"Acta Derm Venerol (Stockh)"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06137.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2004.05.008"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.13.2.187-192.2006"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02967.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.23611.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000073710"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200105)31:5<1317::AID-IMMU1317>3.0.CO;2-I"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/73200"},{"key":"e_1_2_5_34_2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/clinchem\/47.5.952","article-title":"IgG autoantibodies against tissue transglutaminase in relation to antinuclear antibodies","volume":"47","author":"Van Der Sluijs VG","year":"2001","journal-title":"Clin Chem"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051291"},{"key":"e_1_2_5_36_2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/clinchem\/48.7.1133","article-title":"IgG anti\u2010transglutaminase autoantibodies in systemic lupus erythematosus and Sj\u00f6gren syndrome","volume":"48","author":"Villalta D","year":"2002","journal-title":"Clin Chem"},{"key":"e_1_2_5_37_2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/clinchem\/48.2.393","article-title":"Picarelli A. Presence of anti\u2010tissue transglutaninase antibodies as a sign of tissue lesion","volume":"48","author":"Di Tola M","year":"2002","journal-title":"Clin Chem"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400880"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.01845.x"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550310015022"},{"key":"e_1_2_5_41_2","first-page":"170","article-title":"Apoptosis: molecular mechanisms in programmed cell death","volume":"56","author":"Fesus L","year":"1991","journal-title":"Eur J Cell Biol"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12413590"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.7.488"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1080\/0891693031000118974"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2008.02713.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2008.02713.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:33:23Z","timestamp":1697326403000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2008.02713.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,18]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1468-3083.2008.02713.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02713.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,18]]}}}